
Cassel Salpeter & Co.’s Q3 healthcare update points to disrupted NIH grant processing, FDA attrition, and tariffs as pressures on drug development and early-stage financing.
Resources For Diabetes and Obesity
Diabetes
Associations and Societies
Clinical Trials
Obesity
Associations and Societies
Clinical Trials






